drugset / Trial / NCT00470314

Therapeutic Efficacy of L-Ornithine L-Aspartate Infusion in Patients With Acute Liver Failure

NCT00470314

Phase 2 Unknown 150 enrolled All India Institute of Medical Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to determine whether L-Ornithine L-Aspartate infusion improves the survival of patients with acute liver failure.

Timeline

Start
2005-01
Primary completion
Completion
2007-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject L-ornithine L-aspartate Other / unclassified 30 g

Indications